What Is Tesamorelin Used For in Research?
Tesamorelin carries a stabilizing modification at the N-terminus of the native GHRH sequence, which extends its functional half-life to roughly 26 minutes compared to about 7 minutes for unmodified GHRH — while preserving full agonist activity at the pituitary GHRH receptor. This stability is what made it practical to study in formal clinical trials, unlike native GHRH.
Published Phase 3 trial data (Falutz et al., J Clin Endocrinol Metab 2010; Stanley et al., JAMA 2014) documented Tesamorelin's effect specifically on visceral adipose tissue (VAT) — the metabolically active deep abdominal fat linked to cardiometabolic risk — alongside downstream IGF-1 increases and improved lipid profiles in trial populations. This body of clinical data is why Tesamorelin remains one of the best-characterized GHRH-class research peptides.
Despite this trial history, REVIVE LAB UAE sells Tesamorelin exclusively as an unscheduled research chemical for laboratory study, with a lot-specific Certificate of Analysis — not as a prescription product, and not for human or veterinary administration.
Purity ≥ 98.5% (HPLC) · COD, card or Binance Pay (5% off) Order Tesamorelin UAE — Live Stock & Pricing